Recursion Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2021. For the quarter, the company reported total revenue of $2,562,000 compared to $60,000 a year ago. Loss from operations was $30,484,000 compared to $18,343,000 a year ago. Net loss and comprehensive loss $30,717,000 compared to $18,424,000 a year ago. Net loss per share, basic and diluted was $1.33 per share compared to $0.85 a year ago.